| Zacks Company Profile for Bausch Health Cos Inc. (BHC : NYSE) |
|
|
| |
| • Company Description |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Number of Employees: 20,700 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $7.06 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 2,981,410 shares |
| Shares Outstanding: 370.08 (millions) |
| Market Capitalization: $2,612.78 (millions) |
| Beta: 0.41 |
| 52 Week High: $9.85 |
| 52 Week Low: $3.96 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
48.32% |
41.73% |
| 12 Week |
63.43% |
39.59% |
| Year To Date |
-12.41% |
-17.95% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Thomas J. Appio - Chief Executive Officer and Director
John A. Paulson - Chairperson of the Board and Director
Jean-Jacques Charhon - Executive Vice President; Chief Financial Officer
John S. Barresi - Senior Vice President; Controller and Chief Accoun
Christian A. Garcia - Director
|
|
Peer Information
Bausch Health Cos Inc. (BGMR)
Bausch Health Cos Inc. (BBIO)
Bausch Health Cos Inc. (IPAH)
Bausch Health Cos Inc. (BRL)
Bausch Health Cos Inc. (BHC)
Bausch Health Cos Inc. (AKRXQ)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-GENERIC DRG
Sector: Medical
CUSIP: 071734107
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/30/25
|
|
Share - Related Items
Shares Outstanding: 370.08
Most Recent Split Date: 10.00 (2.00:1)
Beta: 0.41
Market Capitalization: $2,612.78 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $1.12 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $3.94 |
Payout Ratio: 0.00 |
| Number of Estimates in the Fiscal Year Consensus: 5.00 |
Change In Payout Ratio: 0.00 |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 07/30/25 |
|
|
|
| |
